Mogrify
PrivateLast Round
Series A
Extension
Oct 2, 2023
Total Funding Raised
$77.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mogrify is a biotechnology company that develops proprietary platform technologies for direct cellular reprogramming to create a novel class of in vivo reprogramming therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mogrify Comparables
Compare Mogrify with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iReprogram, Inc. | 89% | |
| bit.bio | 78% | |
| GC Therapeutics | 77% | |
Mogrify Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 2, 2023 | ||||
| Series A Extension | May 4, 2021 | ||||
| Grant | Jan 28, 2020 | ||||
| Series A | Oct 14, 2019 | ||||
| Seed | Feb 20, 2019 |
Key People
Founding team and executive leadership
Mogrify Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SBRI Healthcare | Grant |
| Innovate UK | Seed |
| Astellas Venture Management | Series A Extension, Series A |
| Ahren Innovation Capital | Series A Extension, Seed, Series A |
| Parkwalk Advisors | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 83% MoM.
- Jan 28, 2020
$1.1M grant received from SBRI Healthcare
Mogrify Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mogrify's valuation, stock price, and market status.